Tanya L Wallace Selected Research

Tanya L Wallace Research Topics

7	Schizophrenia (Dementia Praecox) 01/2021 - 08/2011
3	Cognitive Dysfunction 01/2021 - 08/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 08/2011
2	Down Syndrome (Down's Syndrome) 01/2021 - 08/2011
2	Narcolepsy 01/2019 - 08/2011
2	Central Nervous System Diseases (CNS Diseases) 12/2012 - 01/2011
1	Intellectual Disability (Idiocy) 01/2021
1	Dementia (Dementias) 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Alcoholism (Alcohol Abuse) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019
1	Nervous System Diseases (Neurological Disorders) 10/2011
1	Sleep Deprivation 08/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2011
1	Weight Loss (Weight Reduction) 04/2003
1	Body Weight (Weight, Body) 04/2003

2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2016 - 06/2014
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2015 - 02/2013
2	Cholinergic ReceptorsIBA 10/2011 - 08/2011
1	basmisanilIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	LigandsIBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Biogenic Amines (Biogenic Amine)IBA 01/2019
1	LY2940094IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019
1	Opioid Peptides (Opioid Peptide)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	N-Methylaspartate (NMDA)IBA 04/2016
1	Antipsychotic Agents (Antipsychotics)IBA 06/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2014
1	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 06/2014
1	4- (3,4- dichlorophenyl)- 4,5- dihydrooxazol- 2- ylamineIBA 12/2012
1	Nicotine FDA Link 10/2011
1	Glycine Plasma Membrane Transport ProteinsIBA 08/2011
1	Histamine H3 AntagonistsIBA 08/2011
1	gamma-Aminobutyric Acid (GABA)IBA 08/2011
1	Nicotinic AgonistsIBA 08/2011
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 04/2003

4	Therapeutics 01/2019 - 01/2011
1	Immunotherapy 01/2018